Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pluristem Therapeutc (PSTI)

Pluristem Therapeutc (PSTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pluristem Therapeutc MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 ISR

P: 972-74-710-7259 F: 972-747-1087

Description:

PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from the human placenta, a non-controversial source, and not from embryonic stem cells.

Key Statistics

Overview:

Market Capitalization, $K 55,973
Shares Outstanding, K 15,548
Annual Sales, $ 50 K
Annual Net Income, $ -35,310 K
60-Month Beta 1.05
% of Insider Shareholders 6.70%
% of Institutional Shareholders 94.39%
Float, K 14,506
% Float 93.30%

Growth:

1-Year Return -67.83%
3-Year Return -76.47%
5-Year Return -87.80%
5-Year Revenue Growth -86.84%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/14/19
Earnings Per Share ttm -1.60
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year -800.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 07/25/19

PSTI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.52
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -210.35
Return-on-Assets (Before Tax) -134.24
Profit Margin % -70,620.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1,050.93
Price/Cash Flow N/A
Price/Book 2.56
Book Value/Share 1.40
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar